Ocata Therapeutics Inc. (OCAT) Stock Analysis
DELISTED 2016
What happened to Ocata Therapeutics Inc. (OCAT) stock?
Ocata Therapeutics Inc. (OCAT) no longer trades on public markets. It was delisted in February 2016. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- February 2016
- Last recorded price (historical):
- $8.47 (last quote on record before the February 2016 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Ocata Therapeutics Inc. (OCAT). Ocata Therapeutics Inc. was a biopharmaceutical company focused on developing regenerative medicine therapies for eye diseases. The company's research centered on using stem cell technology to treat conditions like age-related macular degeneration.
Last analyzed: Mar 17, 2026Ocata Therapeutics Inc. (OCAT) Healthcare & Pipeline Overview
More about this archive record
Can I still buy OCAT shares?
No. OCAT stopped trading on public markets in February 2016, so the shares are not available through a broker. Anything you see quoted for OCAT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OCAT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Ocata Therapeutics Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.